Home › Funds › Exome Asset Management LLC › CRBP
Exome Asset Management LLC position in CRBP
CORBUS PHARMACEUTICALS HLDGS · Health Care
Exome Asset Management LLC reported holding 190,714 shares of CRBP (CORBUS PHARMACEUTICALS HLDGS) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.85% of its reported portfolio and ranking #37 among its reported holdings. Exome Asset Management LLC has disclosed CRBP holdings in 9 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Exome Asset Management LLC's CRBP position evolved
Exome Asset Management LLC first disclosed a stake in CRBP in Q1 2024 at 87,846 shares (US$3.4M). The position peaked in Q2 2024 at 84,790 shares, worth US$3.8M. Across 9 filings, Exome Asset Management LLC increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 190,714 shares valued at US$1.3M — an increase of 5,800 shares quarter over quarter.. Notable position changes include a 39% trim in Q4 2025 (shares rose 15% over the following quarter), a 68% increase in Q1 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 87.85K | $3.45M | New |
| Q2 2024 | 84.79K | $3.84M | Reduce |
| Q1 2025 | 289.69K | $1.54M | New |
| Q2 2025 | 277.32K | $1.91M | Reduce |
| Q3 2025 | 229.96K | $2.91M | Reduce |
| Q4 2025 | 139.54K | $1.14M | Reduce |
| Q1 2026 | 234.14K | $2.20M | Add |
| Q2 2026 | 184.91K | $1.73M | Reduce |
| Q3 2026 | 190.71K | $1.30M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRBP and 13F data
CRBP (CORBUS PHARMACEUTICALS HLDGS) is a Health Care company. 21 other funds we track also report a position in CRBP — the largest reported positions include Cormorant Asset Management, LP (US$22.0M), Jones Hill Capital LP (US$6.0M), DIADEMA PARTNERS LP (US$5.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRBP
- Cormorant Asset Management, LP 2.34M sh · $22.00M · Q2 2026
- Jones Hill Capital LP 886.43K sh · $6.05M · Q3 2026
- DIADEMA PARTNERS LP 800.00K sh · $5.46M · Q3 2026
- Sio Capital Management, LLC 766.36K sh · $5.23M · Q3 2026
- Prosight Management, LP 168.38K sh · $1.15M · Q3 2026
More on Exome Asset Management LLC
FAQ
How long has Exome Asset Management LLC held CRBP?
Exome Asset Management LLC has disclosed CRBP holdings in 9 of the last 11 reported quarters, going back to Q1 2024.
What is Exome Asset Management LLC's current position in CRBP?
As of Q3 2026, Exome Asset Management LLC holds 190.71K shares of CRBP (CORBUS PHARMACEUTICALS HLDGS), valued at $1.30M, representing 0.85% of its reported portfolio and ranking #37.
Has Exome Asset Management LLC been buying or selling CRBP?
In the latest 13F filing (Q3 2026), Exome Asset Management LLC increased its position in CRBP. The position peaked in Q2 2024 at 84.79K shares.
Which other funds hold CRBP?
Other major institutional holders of CRBP include Cormorant Asset Management, LP, Jones Hill Capital LP, DIADEMA PARTNERS LP, among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.